Product Recalls in Connecticut

Product recalls affecting Connecticut — including food, drugs, consumer products, medical devices, and vehicles distributed to Connecticut. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,636 recalls have been distributed to Connecticut in the last 12 months.

51,038 total recalls
2,636 in last 12 months

Showing 61816200 of 13,380 recalls

DrugNovember 2, 2018· Bound Tree Medical, LLC

Recalled Item: curaplex Epi Safe Administration and Training Kits Recalled by Bound Tree...

The Issue: Labeling Incorrect Instructions: This recall has been initiated because the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 2, 2018· Sandoz Inc

Recalled Item: Isosorbide Dinitrate Tablets Recalled by Sandoz Inc Due to Cross...

The Issue: Cross Contamination with Other Products

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 2, 2018· Sandoz Inc

Recalled Item: Nitrofurantoin Capsules Recalled by Sandoz Inc Due to Cross Contamination...

The Issue: Cross Contamination with Other Products

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugNovember 2, 2018· Sandoz Inc

Recalled Item: Nitrofurantoin Capsules Recalled by Sandoz Inc Due to Cross Contamination...

The Issue: Cross Contamination with Other Products

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugNovember 1, 2018· Bound Tree Medical, LLC

Recalled Item: Curaplex Epi Safe Kit Recalled by Bound Tree Medical, LLC Due to Labeling:...

The Issue: Labeling: Incorrect or missing Lot and/or Exp Date:The Kit is incorrectly...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugNovember 1, 2018· Bound Tree Medical, LLC

Recalled Item: curaplex Epi Safe Administration and Training Kits # 8600-01100. Kit...

The Issue: Labeling: Incorrect or Missing Lot and/or Exp date: vials of epinephrine...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 29, 2018· Sciegen Pharmaceuticals Inc

Recalled Item: Westminister Irbesartan Tablets Recalled by Sciegen Pharmaceuticals Inc Due...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 29, 2018· Sciegen Pharmaceuticals Inc

Recalled Item: GSMS Irbesartan Tablets Recalled by Sciegen Pharmaceuticals Inc Due to CGMP...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 29, 2018· Akorn, Inc.

Recalled Item: Clindamycin Phosphate Topical Solution USP Recalled by Akorn, Inc. Due to...

The Issue: Failed Impurities/Degradation Specifications; out of specification results...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 29, 2018· Sciegen Pharmaceuticals Inc

Recalled Item: GSMS Irbesartan Tablets Recalled by Sciegen Pharmaceuticals Inc Due to CGMP...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 29, 2018· Sciegen Pharmaceuticals Inc

Recalled Item: Westminister Irbesartan Tablets Recalled by Sciegen Pharmaceuticals Inc Due...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 29, 2018· Westminster Pharmaceuticals Llc

Recalled Item: Westminster Irbesartan Tablets Recalled by Westminster Pharmaceuticals Llc...

The Issue: CGMP Deviations: FDA laboratory testing confirmed traces of NDEA impurity in...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 29, 2018· Westminster Pharmaceuticals Llc

Recalled Item: Westminster Irbesartan Tablets Recalled by Westminster Pharmaceuticals Llc...

The Issue: CGMP Deviations: FDA laboratory testing confirmed traces of NDEA impurity in...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 29, 2018· Sciegen Pharmaceuticals Inc

Recalled Item: Westminister Irbesartan Tablets Recalled by Sciegen Pharmaceuticals Inc Due...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 29, 2018· Sciegen Pharmaceuticals Inc

Recalled Item: GSMS Irbesartan Tablets Recalled by Sciegen Pharmaceuticals Inc Due to CGMP...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 29, 2018· Westminster Pharmaceuticals Llc

Recalled Item: Westminster Irbesartan Tablets Recalled by Westminster Pharmaceuticals Llc...

The Issue: CGMP Deviations: FDA laboratory testing confirmed traces of NDEA impurity in...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 26, 2018· Dr. Reddy's Laboratories, Inc.

Recalled Item: Levetiracetam in 0.54 % Sodium Chloride Injection 1 Recalled by Dr. Reddy's...

The Issue: Labeling: Label Error on Declared Strength; the pre-printed text on the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugOctober 23, 2018· Janssen Pharmaceuticals, Inc.

Recalled Item: Ortho-Novum 1/35 (norethindrone/ethinyl estradiol) Tablets Recalled by...

The Issue: Labeling: Incorrect Instructions; Instructions included for use with the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 23, 2018· Janssen Pharmaceuticals, Inc.

Recalled Item: Ortho-Novum 7/7/7 (norethindrone/ethinyl/estradiol) Tablets Recalled by...

The Issue: Labeling: Incorrect Instructions; Instructions included for use with the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2018· Boehringer Ingelheim Pharmaceuticals, Inc.

Recalled Item: Catapres .2 (clonidine hydrochloride Recalled by Boehringer Ingelheim...

The Issue: Failed Dissolution Specifications: OOS resultsduring routine stability testing

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund